SLCTR_2018_042

The effect of a synbiotic (probiotic and prebiotic) supplementation on patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A proof of concept study

Name: Clinical Trial SLCTR_2018_042
Creator: Durdans Hospital, 3, Alfred place, Colombo 3
Keywords: Non-Alcoholic Fatty Liver Disease, Early Phase 1, clinical trial, Sri Lanka

Durdans Hospital, 3, Alfred place, Colombo 3·Early Phase 1·Sri Lanka Clinical Trials RegistryRecruiting

Study focus

Disease/Condition: Non-Alcoholic Fatty Liver Disease
Study type: Interventional

Sponsor & location

Primary sponsor: Durdans Hospital, 3, Alfred place, Colombo 3
Location: Sri Lanka

Timeline & enrollment

Phase: Early Phase 1
Start date: Jan 07, 2019
End date: N/A

ICD-10 classifications

Alcoholic fatty liverAlcoholic liver disease, unspecifiedAlcoholic liver diseaseLiver disease, unspecifiedAlcoholic cirrhosis of liver

Data source

Registry: Sri Lanka Clinical Trials Registry
Trial ID: SLCTR_2018_042
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for SLCTR_2018_042 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by Durdans Hospital, 3, Alfred place, Colombo 3 and is currently Recruiting. The study focuses on Non-Alcoholic Fatty Liver Disease.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.